Multimodal physiotherapy as an add-on treatment to botulinum toxin type A therapy in patients with cervical dystonia: a pilot trial”

Not Applicable

Recruiting

• Conditions: G24; Dystonia

• Registration Number: DRKS00006562
• Lead Sponsor: niversitätsklinikum Jena, Institut f. Physiotherapie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-09-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Cervical dystonia diagnosed

- Continuous treatment with botulinumtoxin in an three months interval

- At least one year treatment with botulinumtoxin

Exclusion Criteria

- Contraindications for the physiotherapy treatment

- Contraindications for the botulinumtoxin treatment

- Refusal of the study participation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main object of this study is to validate the effectiveness of a multimodal PT program as an additional therapy to BTX injection versus BTX application alone.<br>Primary objectives are the quality of life determined by the SF-36 score and the mobility of the cervical spine which will be detected by the measuring system ZEBRIS.<br>These assessments will be collected at the beginning and repeated at an interval of six weeks until the end of the study.

Secondary Outcome Measures

Name	Time	Method
Secondary object is the Toronto Western Spasmodic Rating Scale (TWSTRS) which includes severity, disability and pain of the cervical dystonia. Another secondary variable is the electrical activity from the concerned muscles measured by an surface electromyography.<br>These assessments will be collected at the beginning and repeated at an interval of six weeks until the end of the study.